NYSEAMERICAN:NSPR - InspireMD Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$0.19 0.00 (0.00 %)
(As of 01/22/2019 04:00 PM ET)
Previous Close$0.1949
Today's Range$0.18 - $0.21
52-Week Range$0.13 - $9.17
Volume2.25 million shs
Average Volume1.37 million shs
Market Capitalization$7.14 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of coronary and vascular diseases. The company offers CGuard carotid embolic prevention systems for use in carotid artery applications; and MGuard prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions. It is also developing NGuard, a neurovascular flow diverter that diverts blood flow away from cerebral aneurysms in order to seal the aneurysms. InspireMD, Inc. distributes its products in Europe, Latin America, the Middle East, and Asia. The company is headquartered in Tel Aviv, Israel.

Receive NSPR News and Ratings via Email

Sign-up to receive the latest news and ratings for NSPR and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN
Industry Medical Appliances & Equipment
Sub-IndustryN/A
SectorMedical
Current SymbolNYSEAMERICAN:NSPR
Previous SymbolNASDAQ:NSPR
CUSIPN/A
Phone+1-857-4536553

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees36
Market Cap$7.14 million
OptionableNot Optionable

InspireMD (NYSEAMERICAN:NSPR) Frequently Asked Questions

What is InspireMD's stock symbol?

InspireMD trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "NSPR."

When did InspireMD's stock split? How did InspireMD's stock split work?

InspireMD's stock reverse split on Thursday, February 8th 2018. The 1-35 reverse split was announced on Wednesday, February 7th 2018. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, February 7th 2018. An investor that had 100 shares of InspireMD stock prior to the reverse split would have 3 shares after the split.

How were InspireMD's earnings last quarter?

InspireMD Inc (NYSEAMERICAN:NSPR) issued its earnings results on Tuesday, November, 6th. The medical equipment provider reported ($0.05) EPS for the quarter. The medical equipment provider earned $0.77 million during the quarter. View InspireMD's Earnings History.

When is InspireMD's next earnings date?

InspireMD is scheduled to release their next quarterly earnings announcement on Wednesday, February 13th 2019. View Earnings Estimates for InspireMD.

Has InspireMD been receiving favorable news coverage?

Media stories about NSPR stock have trended very positive on Tuesday, InfoTrie Sentiment reports. The research firm scores the sentiment of press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. InspireMD earned a coverage optimism score of 3.2 on InfoTrie's scale. They also gave news articles about the medical equipment provider a news buzz of 4.0 out of 10, meaning that recent press coverage is somewhat unlikely to have an impact on the company's share price in the near term.

Are investors shorting InspireMD?

InspireMD saw a drop in short interest in the month of December. As of December 31st, there was short interest totalling 1,380,239 shares, a drop of 26.2% from the December 14th total of 1,869,651 shares. Based on an average trading volume of 732,618 shares, the days-to-cover ratio is presently 1.9 days. Currently, 3.9% of the company's shares are sold short. View InspireMD's Current Options Chain.

Who are some of InspireMD's key competitors?

Who are InspireMD's key executives?

InspireMD's management team includes the folowing people:
  • Dr. James J. Barry, Pres, CEO & Director (Age 60)
  • Mr. Craig Shore, CFO, Chief Admin. Officer, Sec. & Treasurer (Age 58)
  • Mr. Agustin V. Gago, Exec. VP & Chief Commercial Officer (Age 59)
  • Dr. Sol J. Barer, Special Advisor to the Board (Age 72)
  • Mr. Benzi Spector, Head of R&D and Operations

Who are InspireMD's major shareholders?

InspireMD's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Virtu Financial LLC (0.77%). Company insiders that own InspireMD stock include Paul Stuka and Thomas J Kester. View Institutional Ownership Trends for InspireMD.

Which institutional investors are buying InspireMD stock?

NSPR stock was bought by a variety of institutional investors in the last quarter, including Virtu Financial LLC. View Insider Buying and Selling for InspireMD.

How do I buy shares of InspireMD?

Shares of NSPR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is InspireMD's stock price today?

One share of NSPR stock can currently be purchased for approximately $0.19.

How big of a company is InspireMD?

InspireMD has a market capitalization of $7.14 million. InspireMD employs 36 workers across the globe.

What is InspireMD's official website?

The official website for InspireMD is http://www.inspiremd.com/.

How can I contact InspireMD?

InspireMD's mailing address is 4 Menorat Hamaor St., TEL AVIV-YAFO, MA 6744832, Israel. The medical equipment provider can be reached via phone at +1-857-4536553.


MarketBeat Community Rating for InspireMD (NYSEAMERICAN NSPR)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  123 (Vote Outperform)
Underperform Votes:  117 (Vote Underperform)
Total Votes:  240
MarketBeat's community ratings are surveys of what our community members think about InspireMD and other stocks. Vote "Outperform" if you believe NSPR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NSPR will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/22/2019 by MarketBeat.com Staff

Featured Article: Intrinsic Value

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel